A candidate drug, which acts in a novel way, has shown promising results in the laboratory against advanced prostate cancer that was insensitive to reduced levels of male sex hormones, according to
Cuban scientists said they have concluded the second round of the clinical trial of a potential vaccine against prostate cancer.
The Food and Drug Administration approved the first treatment that uses a so-called cancer vaccine, a drug that trains the body
Forfeiting our commons
The Lancet’s Series on Maternal and Child Undernutrition
President Obama's grand climate plan does not add up
Climate change can no longer be ignored
NGO demands withdrawal of Niyamgiri gram sabha notificatio